Comments

CRISPR Therapeutics Stock Price, Quotes and Forecasts

CRSPNASDAQ
Logo brought to you by Benzinga Data
PerksTrade with Public
PerksTrade with Public
$63.75
At close: Jul 29 EDT
$63.74
-0.01000-0.02%
Pre-Market: 7:21 AM EDT

CRISPR Therapeutics (CRSP) Forecast

NewsEarningsCRISPR Therapeutics (CRSP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort Interest
Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

CRISPR Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CRSP | Benzinga

Explore CRISPR Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRSP.

Open-
Close-
Volume / Avg.5.25K / 3.00M
Day Range- - -
52 Wk Range30.04 - 71.13
Market Cap$5.50B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
63
Short Interest
33.3%
Days to Cover7.71

Recent News

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
Rounak Jain
Cathie Wood Doesn't Need Tesla To Win—ARKK Delivers A Blowout While EV Giant Idles
During the pandemic-fueled boom of 2020, Cathie Wood's Ark Innovation ETF (NYSE:ARKK) was one of the hottest funds on Wall Street, surging nearly 400% off its March 2020 lows. But that euphoria peaked in February 2021.
Piero Cingari
Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
7
3
1
Feb
1
Apr
4
2
May
4
Jun
2
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open-
Close-
Volume / Avg.5.25K / 3.00M
Day Range- - -
52 Wk Range30.04 - 71.13
Market Cap$5.50B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
63
Short Interest
33.3%
Days to Cover7.71
About CRISPR Therapeutics AG
Sector
Healthcare
Industry
N/A
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therap...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CRSP

FAQ

Q

How do I buy CRISPR Therapeutics (CRSP) stock?

A

You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CRISPR Therapeutics (CRSP) competitors?

A

There are no as such competitors for CRISPR Therapeutics.

Q

What is the forecast, or price target, for CRISPR Therapeutics (CRSP) stock?

A

CRISPR Therapeutics has a consensus price target of $70.21.

Q

What is the current price for CRISPR Therapeutics (CRSP)?

A

The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $63.74 last updated July 29, 2025 at 7:21 AM EDT.

Q

Does CRISPR Therapeutics (CRSP) pay a dividend?

A

There are no upcoming dividends for CRISPR Therapeutics.

Q

When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?

A

CRISPR Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Q

Is CRISPR Therapeutics (CRSP) going to split?

A

There is no upcoming split for CRISPR Therapeutics.

Q

What sector and industry does CRISPR Therapeutics (CRSP) operate in?

A

CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved